Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | cefamandole | 4421 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | terbutaline | 5403 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | terbutaline | 5403 | drug-path |
Tight junction | R-HSA-2134514 | map04530 | terbutaline | 5403 | drug-path |
Homologous recombination | R-HSA-5685942 | map03440 | terbutaline | 5403 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | terbutaline | 5403 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | terbutaline | 5403 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | terbutaline | 5403 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | terbutaline | 5403 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | terbutaline | 5403 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | nortriptyline | 4543 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | nortriptyline | 4543 | drug-path |
Non-homologous end-joining | R-HSA-5693571 | map03450 | nortriptyline | 4543 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | nortriptyline | 4543 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | nortriptyline | 4543 | drug-path |
Insulin signaling pathway | R-HSA-74752 | map04910 | piromidic acid | 4855 | drug-path |
Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | piromidic acid | 4855 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | piromidic acid | 4855 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | piromidic acid | 4855 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | piromidic acid | 4855 | drug-path |